TOP-group | Agreementa | Kappa | Sensitivity | Specificity | PPV | NPV | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Est. | 95% CI | Est. | 95% CI | Est. | 95% CI | Est. | 95% CI | Est. | 95% CI | Est. | 95% CI | ||
SCZ | All | .87 | .85–.89 | .74 | .68–.80 | .84 | .81–.87 | .90 | .87–.92 | .88 | .86–.91 | .86 | .83–.89 |
Men | .85 | .82–.88 | .69 | .61–.77 | .84 | .81–.88 | .86 | .81–.90 | .89 | .86–.93 | .79 | .74–.84 | |
Women | .89 | .87–.92 | .77 | .68–.85 | .84 | .78–.89 | .93 | .90–.95 | .87 | .82–.92 | .91 | .88–.94 | |
Pre NPRb | .88 | .85–.91 | .76 | .67–.84 | .85 | .81–.90 | .91 | .87–.94 | .89 | .85–.93 | .87 | .83–.91 | |
Post NPRc | .86 | .83–.89 | .72 | .63–.81 | .83 | .79–.88 | .89 | .85–.93 | .88 | .84–.92 | .85 | .81–.89 | |
DEL | All | .92 | .90–.93 | .39 | .34–.44 | .69 | .55–.82 | .93 | .92–.95 | .31 | .22–.40 | .99 | .98–.99 |
Men | .90 | .88–.92 | .35 | .27–.42 | .61 | .43–.79 | .92 | .89–.94 | .29 | .18–.41 | .98 | .96–.99 | |
Women | .94 | .92–.96 | .45 | .37–.53 | .82 | .62–1.0 | .95 | .93–.97 | .33 | .18–.48 | .99 | .99–1.0 | |
Pre NPRb | .94 | .92–.96 | .32 | .24–.39 | .57 | .27–.87 | .95 | .93–.97 | .24 | .09–.40 | .99 | .98–1.0 | |
Post NPRc | .90 | .88–.93 | .42 | .34–.49 | .74 | .58–.89 | .91 | .89–.93 | .34 | .23–.45 | .98 | .97–.99 | |
SCA | Total | .92 | .91–.94 | .63 | .57–.69 | .76 | .68–.84 | .94 | .93–.96 | .61 | .53–.69 | .97 | .96–.98 |
Men | .93 | .91–.95 | .55 | .47–.63 | .69 | .54–.84 | .95 | .93–.97 | .51 | .38–.64 | .98 | .96–.99 | |
women | .92 | .89–.94 | .68 | .60–.77 | .80 | .71–.89 | .93 | .91–.96 | .67 | .57–.77 | .97 | .95–.98 | |
Pre NPRb | .91 | .89–.94 | .59 | .51–.68 | .73 | .61–.85 | .93 | .91–.96 | .57 | .45–.69 | .97 | .95–.98 | |
Post NPRc | .93 | .91–.95 | .67 | .59–.75 | .79 | .69–.90 | .95 | .93–.97 | .64 | .53–.75 | .97 | .96–.99 | |
BIP | Total | .87 | .85–.89 | .72 | .66–.78 | .78 | .74–.82 | .92 | .90–.94 | .86 | .82–.89 | .88 | .86–.90 |
Men | .90 | .87–.92 | .74 | .66–.82 | .78 | .71–.84 | .94 | .92–.96 | .84 | .78–.90 | .92 | .89–.94 | |
women | .85 | .82–.88 | .69 | .60–.77 | .79 | .73–.84 | .90 | .86–.93 | .87 | .82–.91 | .83 | .79–.87 | |
Pre NPRb | .86 | .83–.89 | .68 | .60–.77 | .72 | .66–.78 | .94 | .91–.96 | .88 | .83–.93 | .84 | .81–.88 | |
Post NPRc | .89 | .86–.91 | .76 | .67–.84 | .85 | .80–.90 | .91 | .88–.94 | .84 | .78–.89 | .92 | .89–.95 |